Nov 13, 2021

 

Dr. Noelle Ebel, recipient of the 2021 Leonard B. Seeff Award for Outstanding Research by an Early Career Investigator, was part of a team that created the largest North American registry for COVID-19 infection in children with liver transplants.

Dr. Ebel will present her award-winning research this Monday, November 15th during Parallel 31: Clinical/ Translational Research in Pediatric Hepatology (12:30 PM – 2 PM EST).

“We report the largest international registry study of pediatric transplant recipients with COVID infection, which reported no deaths or the requirement for mechanical ventilation. This registry study helps continue to inform pediatric transplant recipients, their families and medical providers. As the pandemic evolves, the registry also evolves with the current aim to understand COVID infection in transplant patients following vaccination.”

Dr. Ebel was previously recognized by AASLD in 2016 for her work that found poorer outcomes in graft and patient survival in young adults 18-24 years old, compared to both older and younger age groups. In 2017 Dr. Ebel was the recipient of the AASLD Foundation Advanced/Transplant Hepatology Fellowship Award. In 2019 her oral presentation at the AASLD Liver Meeting described the novel finding that pediatric liver transplant recipients with technical variant grafts had decreased odds of developing hepatic artery thrombosis. Most recently she partnered with colleagues in the Society of Pediatric Liver Transplantation (SPLIT) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) to create an international COVID-19 registry for pediatric patients with chronic liver disease and liver and intestinal transplant recipients.

Dr. Ebel is an Assistant Clinical Professor at Stanford University where she is the Director of the Alagille Syndrome program and Program Director for the Transplant Hepatology fellowship. Her clinical and research interests lie at the intersection of the heart and the liver, specifically Fontan associated liver disease, indications for combined heart-liver transplantation and support children with Alagille syndrome with liver disease requiring pulmonary artery reconstruction. She remains committed to addressing health disparities in pediatric liver transplantation and is the Director of Policy in the Office of Child Health Equity at Stanford University.

To learn more about this year’s AASLD Foundation Abstract Awardees, filter by “AASLD Foundation Abstract Award” in the TLMdX program planner.